New digital scope could help rectal cancer patients avoid surgery
NCT ID NCT06189846
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new digital scope called LUMENEYE to see if it can better measure how much a rectal tumor has shrunk after chemotherapy and radiation. 82 patients who were good candidates for organ preservation were included. The goal was to see if the scope could help doctors decide who can safely skip surgery and keep their rectum.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LUMENEYE rectoscope (a digital endoscope device)
What this could lead to
If successful, this could help doctors more accurately decide which rectal cancer patients can safely avoid surgery and preserve their rectum after chemotherapy and radiation.
What could go wrong
This is a small, completed observational study (82 people) that only measures how well the device agrees with standard tests. It does not test a new treatment or prove long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amsterdam UMC
Amsterdam, Netherlands
-
CHU de ROUEN
Rouen, France
-
Clinique Tivoli-Ducos - Bordeaux Colorectal Institute
Bordeaux, France
-
Humanitas Research Hospital
Milan, Italy
-
Hôpital Européen de Marseille
Marseille, France
-
Hôpital Saint-Antoine - APHP
Paris, France
-
Imperial College London
London, United Kingdom
-
University Hospital Vall D'Hebron
Barcelona, Spain